Amdocs Limited $DOX Stock Holdings Boosted by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC

Key Points

• UBS Asset Management increased its stake in Amdocs Limited by 3.9%, now owning 477,898 shares worth approximately $43.73 million.
• Amdocs recently reported earnings of $1.72 per share, which surpassed analyst expectations, while also experiencing an 8.4% year-over-year decline in revenue.
• The company announced a quarterly dividend of $0.527 per share, which will be paid on October 31st, representing a 2.5% dividend yield.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 3.9% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 477,898 shares of the technology company's stock after buying an additional 18,068 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 0.42% of Amdocs worth $43,728,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. LSV Asset Management lifted its stake in Amdocs by 11.1% during the first quarter. LSV Asset Management now owns 3,180,501 shares of the technology company's stock valued at $291,016,000 after buying an additional 317,412 shares in the last quarter. Alyeska Investment Group L.P. grew its position in Amdocs by 38.6% in the first quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company's stock worth $213,174,000 after acquiring an additional 648,693 shares in the last quarter. American Century Companies Inc. raised its position in shares of Amdocs by 23.5% in the first quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company's stock valued at $205,219,000 after purchasing an additional 426,911 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Amdocs by 9.4% in the first quarter. Dimensional Fund Advisors LP now owns 2,120,075 shares of the technology company's stock valued at $193,978,000 after purchasing an additional 182,489 shares during the period. Finally, AQR Capital Management LLC raised its position in shares of Amdocs by 43.0% in the first quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company's stock valued at $86,719,000 after purchasing an additional 287,243 shares during the period. Institutional investors own 92.02% of the company's stock.

Amdocs Price Performance

Shares of DOX opened at $85.00 on Monday. Amdocs Limited has a 1 year low of $78.61 and a 1 year high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22. The company has a market capitalization of $9.60 billion, a price-to-earnings ratio of 17.24, a price-to-earnings-growth ratio of 1.55 and a beta of 0.54. The business has a 50-day moving average of $87.18 and a 200-day moving average of $88.54.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The business had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same period in the previous year, the company posted $1.62 earnings per share. The firm's revenue for the quarter was down 8.4% on a year-over-year basis. As a group, equities research analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a dividend of $0.527 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. Amdocs's payout ratio is presently 42.60%.

Analysts Set New Price Targets

DOX has been the topic of several research analyst reports. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Wolfe Research started coverage on Amdocs in a report on Tuesday, July 8th. They set an "outperform" rating for the company. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Amdocs presently has an average rating of "Buy" and an average price target of $105.33.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.